Dexmedetomidine for Continuous Sedation

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The study aims to demonstrate that dexmedetomidine is non-inferior to current best practice sedation with propofol/midazolam and daily sedation stops, in maintaining a target depth of sedation in long-stay intensive care unit (ICU) patients, and that dexmedetomidine, compared with current best practice, reduces the length of ICU stay.
Epistemonikos ID: 0e924698e994c827a7c4ead4d6ad48a5ee0ed5db
First added on: May 04, 2024